Optimizing ADHD therapy with sustained-release methylphenidate

American Family Physician

Volumn 55, Issue 5, 1997, Pages 1705-1709

  Lawrence, Julie D ^a   Lawrence, David B ^a   Carson, Deborah Stier ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; IMIPRAMINE; METHYLPHENIDATE; PEMOLINE; PEMOLINE MAGNESIUM; PLACEBO; PSYCHOSTIMULANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; DRUG ABUSE; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; REVIEW; SIDE EFFECT; SOMNOLENCE; SUSTAINED RELEASE PREPARATION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DELAYED-ACTION PREPARATIONS; HUMANS; METHYLPHENIDATE;

EID: 0030953556     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Safer DJ, Krager JM. A survey of medication treatment for hyperactive/inattentive students. JAMA 1988;260:2256-8.
2. Varley CK. Effects of methylphenidate in adolescents with attention deficit disorders. J Am Acad Child Psychiatry 1983;22:351-4.
3. Klorman R, Coons HW, Borgstedt AD. Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder. I. Clinical findings. J Am Acad Child Adolesc Psychiatry 1987;26:363-7.
4. Pelham WE Jr, Sturges J, Hoza J, Schmidt C, Bijlsma JJ, Milich R, et al. Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder. Pediatrics 1987;80:491-501.
5. Elia J. Drug treatment for hyperactive children. Therapeutic guidelines. Drugs 1993;46:863-71.
6. Patrick KS, Mueller RA, Gualtieri CT, Breese GR. Pharmacokinetics and actions of methylphenidate. In: Meltzer HY, ed. Psychopharmacology. The third generation of progress. New York: Raven, 1987:1387-95.
7. Pelham WE Jr, Greenslade KE, Vodde-Hamilton M, Murphy DA, Greenstein JJ, Gnagy EM, et al. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics 1990;86:226-37.
8. Greenhill LL. Pharmacologic treatment of attention deficit hyperactivity disorder. Pediatric Psychopharmacol 1992;14:1-27.
9. Brown GL, Ebert MH, Mikkelson EJ, Hunt RD. Behavior and motor activity response in hyperactive children and plasma amphetamine levels following a sustained release preparation. J Am Acad Child Adolesc Psychiatry 1980;19:225-39.
10. Patrick KS, Straughn AB, Jarvi EJ, Breese GR, Meyer MC. The absorption of sustained-release methylphenidate formulations compared to an immediate-release formulation. Biopharm Drug Dispos 1989; 10:165-71.
11. Sleator EK, Ullman RK, von Neumann A. How do hyperactive children feel about taking stimulants and will they tell the doctor? Clin Pediatr 1982;21:474-9.
12. Firestone P. Factors associated with children's adherence to stimulant medication. Am J Orthopsychiatry 1982;52:447-57.
13. Bowen J, Fenton T, Rappaport L. Stimulant medication and attention deficit-hyperactivity disorder. The child's perspective. Am J Dis Child 1991;145:291-5.
14. Wolraich ML, Lindgren S, Stromquist A, Milich R, Davis C, Waton D. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics 1990;86:95-101.
15. Fitzpatrick PA, Klorman R, Brumaghim JT, Borgstedt AD. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1992;31:226-34.
16. Birmaher B, Greenhill LL, Cooper TB, Fried J, Maminski B. Sustained release methylphenidate: pharmacokinetic studies in ADHD males. J Am Acad Child Adolesc Psychiatry 1989;28:768-72.
17. Whitehouse D, Shah U, Palmer FB. Comparison of sustained-release and standard methylphenidate in the treatment of minimal brain dysfunction. J Clin Psychiatry 1980;41:282-5.
18. Connors CK. A teacher rating scale for use in drug studies with children. Am J Psychiatry 1969;126:884-8.
19. Brown RT, Borden KA, Wynne ME, Spunt AL, Clingerman SR. Compliance with pharmacological and cognitive treatments for attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1987;26:521-6.
20. Kaufman RE, Smith-Wright D, Reese CA, Simpson R, Fowler J. Medication compliance in hyperactive children. Pediatric Pharmacology 1981;1:231-7.
21. Ahmann PA, Waltonen SJ, Olson KA, Theye FW, Van Erem AJ, LaPlant RJ. Placebo-controlled evaluation of ritalin side effects. Pediatrics 1993;91:1101-6.